EP0480971A1 - A method for introducing molecules, particularly genetic material, into plant cells - Google Patents

A method for introducing molecules, particularly genetic material, into plant cells

Info

Publication number
EP0480971A1
EP0480971A1 EP19900910596 EP90910596A EP0480971A1 EP 0480971 A1 EP0480971 A1 EP 0480971A1 EP 19900910596 EP19900910596 EP 19900910596 EP 90910596 A EP90910596 A EP 90910596A EP 0480971 A1 EP0480971 A1 EP 0480971A1
Authority
EP
European Patent Office
Prior art keywords
plant cells
cells
molecules
genetic material
ultrasound treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP19900910596
Other languages
German (de)
English (en)
French (fr)
Inventor
Morten Jorsboe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Sandoz AG
Original Assignee
Sandoz Erfindungen Verwaltungs GmbH
Sandoz AG
Danisco AS
Danisco US Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Erfindungen Verwaltungs GmbH, Sandoz AG, Danisco AS, Danisco US Inc filed Critical Sandoz Erfindungen Verwaltungs GmbH
Publication of EP0480971A1 publication Critical patent/EP0480971A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8206Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by physical or chemical, i.e. non-biological, means, e.g. electroporation, PEG mediated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Definitions

  • the method according to the invention is a useful alternative to previously known introduction methods.
  • the method provides a new approach involving only moderate costs, said method being carried out quickly and simply. Based on introduction experiments already conducted it can be predicted that the method will also turn out to be superior when used for a great number of other biological materials, where known methods are insufficient.
  • the plant cells are subjected to an ultrasound treatment considerably milder than the ultrasound treatment used for homogenizing or lysing cells. It is important that the treatment is suitably mild so that a sufficient number of plant cells remain viable.
  • the plant cell suspension can advantageously be exposed to ultrasonic waves of a frequency range of from 5 kHz to 10 MHz, particularly from 10 to 100 kHz, and an electric output power (i.e.
  • the method according to the invention has advantageously been used to introduce molecules into cells of sugar beet and tobacco plants.
  • the medium can be any suitable, conventional medium for cells or protoplasts.
  • the method according to the invention uses a technique presumbably resulting in a temporary moderate weakening of both the cell membrane and the cell wall, which is shown in intact plant cells in the following examples. The examples thus show that plasmid DNA can penetrate plant cells having been treated with ultrasound.
  • CPW is an aqueous solution of a mixture of inorganic salts comprising i.a. approx. 10 mM Ca , described by Frearson et al., (Dev. Biol., 33, 130-137, 1973).
  • a cell suspension for ultrasound treatment is prepared by removing cells 3 to 4 days after sub-culturing and washing them twice with CPW 13S (i.e. CPW containing 13% sorbitol), finally suspending said cells in CPW 13S at a ratio of 1 part by volume cells to 4 parts by volume CPW 13S. Then plasmid DNA is added to the suspension in 0.35 ml CPW containing 21% sucrose and plant cells (500.000/ml) in an Eppendorf tube, the final plasmid concentration being 45 ⁇ g/ml.
  • CPW 13S i.e. CPW containing 13% sorbitol
  • the plasmid DNA used is a plasmid coding for the marker enzyme chloramphenicol-acetyltransferase (CAT) , in this case the plasmid pCaMVCN having the code 27-4909, available from Pharmacia LKB Biotechnology, Uppsala, Sweden.
  • CAT chloramphenicol-acetyltransferase
  • the present example illustrates the introduction of plasmid DNA into intact sugar beet cells of the genotype Ml.
  • the suspension culture of sugar beet cells is maintained by sub-culturing as described above and is treated with ultrasound, cultured and analysed in the manner described.
  • the results of the measured CAT-activity appear from Table 1.
  • the present example illustrates the introduction of plasmid DNA into intact tobacco cells.
  • the cells are removed 3 to 4 days after sub-culturing and washed twice with CPW 13S (i.e. CPW containing 13% sorbitol), finally suspending said cells in CPW 13S at a ratio of 1 part by volume cells to 4 parts by volume CPW 13S.
  • Samples of 0.35 ml each are taken out and the plasmid pCaMVCN is added to each sample, the final plasmid concentration being 100 ⁇ g/ml.
  • the cells are then subjected to ultrasound treatment under the conditions appearing from Table 2. After culturing for 2 days in the above-mentioned medium the cells are extracted and their CAT-activity is measured. The results appear from Table 2.
  • the method according to the invention can be used to introduce molecules into intact plant cells.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19900910596 1989-06-29 1990-06-28 A method for introducing molecules, particularly genetic material, into plant cells Ceased EP0480971A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK325189A DK168302B1 (da) 1989-06-29 1989-06-29 Fremgangsmåde til indføring af molekyler, især genetisk materiale i planteceller
DK3251/89 1989-06-29

Publications (1)

Publication Number Publication Date
EP0480971A1 true EP0480971A1 (en) 1992-04-22

Family

ID=8120791

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900910596 Ceased EP0480971A1 (en) 1989-06-29 1990-06-28 A method for introducing molecules, particularly genetic material, into plant cells

Country Status (5)

Country Link
EP (1) EP0480971A1 (da)
JP (1) JPH05500304A (da)
AU (1) AU645260B2 (da)
DK (1) DK168302B1 (da)
WO (1) WO1991000358A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2042093C (en) * 1990-05-09 2002-12-24 Gyula Hadlaczky Cell line carrying an excess of mammalian centromeres
EP0848755B2 (en) 1995-09-08 2011-02-09 Genentech, Inc. Vegf-related protein
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
US6030945A (en) * 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
US5693512A (en) * 1996-03-01 1997-12-02 The Ohio State Research Foundation Method for transforming plant tissue by sonication
JP2000507829A (ja) 1996-04-01 2000-06-27 ジェネンテック インコーポレーテッド Apo―2liおよびapo―3アポトーシスポリペプチド
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6159462A (en) * 1996-08-16 2000-12-12 Genentech, Inc. Uses of Wnt polypeptides
US5851984A (en) * 1996-08-16 1998-12-22 Genentech, Inc. Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
US6462176B1 (en) 1996-09-23 2002-10-08 Genentech, Inc. Apo-3 polypeptide
US5990281A (en) 1996-09-30 1999-11-23 Genentech, Inc. Vertebrate smoothened proteins
US6342369B1 (en) 1997-05-15 2002-01-29 Genentech, Inc. Apo-2-receptor
AU739350B2 (en) 1997-06-05 2001-10-11 University Of Texas System, The APAF-1, the CED-4 human homolog, an activator of caspase-3
EP1032661A1 (en) 1997-06-18 2000-09-06 Genentech, Inc. Apo-2DcR
US6342220B1 (en) 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
DE69939732D1 (de) 1998-01-15 2008-11-27 Genentech Inc Apo-2 ligand
US6114603A (en) * 1998-03-27 2000-09-05 John Innes Center Genetic engineering of sugarbeet plants
WO2001060397A1 (en) 2000-02-16 2001-08-23 Genentech, Inc. Uses of agonists and antagonists to modulate activity of tnf-related molecules
DE19834612A1 (de) * 1998-07-31 2000-02-24 Dornier Medtech Holding Int Gmbh Verfahren zum intrazellulären Transfer von Oligonukleotiden und Vorrichtung zur Durchführung desselben
US6195936B1 (en) * 1999-02-22 2001-03-06 University Of Iowa Research Foundation Method for uptake of a substance into a seed
WO2001000832A1 (en) 1999-06-28 2001-01-04 Genentech, Inc. Methods for making apo-2 ligand using divalent metal ions
DE19962904A1 (de) * 1999-12-23 2001-08-09 Dornier Medizintechnik Verfahren zum Transfer von Molekülen in Zellen und Vorrichtung zur Durchführung des Verfahrens
US20050287647A9 (en) 2001-05-30 2005-12-29 Carl Perez Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
ES2386346T3 (es) 2001-08-29 2012-08-17 Genentech, Inc. Ácidos nucleicos y polipéptidos Bv8 con actividad mitógena
IL161051A0 (en) 2001-10-02 2004-08-31 Genentech Inc Apo-2 ligand variants and uses thereof
EP2332531B1 (en) 2001-11-13 2019-07-10 Genentech, Inc. Methods of purifying Apo2-Ligand/TRAIL
DE10223196B4 (de) 2002-05-24 2004-05-13 Dornier Medtech Systems Gmbh Verfahren und Einrichtung zum Transferieren von Molekülen in Zellen
CA2489348A1 (en) 2002-06-24 2003-12-31 Genentech, Inc. Apo-2 ligand/trail variants and uses thereof
EP2526960A1 (en) 2003-03-12 2012-11-28 Genentech, Inc. Use of BV8 and/or EG-VEGF to promote hematopoiesis
ES2537738T3 (es) 2003-06-05 2015-06-11 Genentech, Inc. Terapia de combinación para trastornos de células B
US20060246044A1 (en) 2004-12-15 2006-11-02 Dornier Medtech System Gmbh Methods for improving cell therapy and tissue regeneration in patients with cardiovascular and neurological diseases by means of shockwaves
GB2452543B (en) * 2007-09-07 2012-07-25 Wei Huang Nucleic acid transfer techniques
AU2008312406B2 (en) 2007-10-16 2014-03-06 Ares Trading S.A. Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease
US8669085B2 (en) 2009-02-05 2014-03-11 Ut-Battelle, Llc Transformation of gram positive bacteria by sonoporation
LT2464725T (lt) 2009-08-11 2020-06-10 F. Hoffmann-La Roche Ag Baltymų gamyba ląstelių mitybinėje terpėje, kurioje nėra glutamino
WO2012151317A1 (en) 2011-05-03 2012-11-08 Genentech, Inc. Vascular disruption agents and uses thereof
KR101791563B1 (ko) * 2015-05-11 2017-11-02 대한민국 음파를 이용한 과실의 성숙을 지연시키는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3537261A1 (de) * 1985-10-19 1987-04-30 Gca Corp Verfahren und medium zum feldinduzierten einschleusen von makromolekuelen in lebende zellen
CA1328236C (en) * 1987-05-05 1994-04-05 Novartis Ag Plant tissue transformation
GB8721015D0 (en) * 1987-09-07 1987-10-14 Amersham Int Plc Modifying living cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9100358A1 *

Also Published As

Publication number Publication date
DK325189D0 (da) 1989-06-29
DK168302B1 (da) 1994-03-07
AU6043290A (en) 1991-01-17
JPH05500304A (ja) 1993-01-28
DK325189A (da) 1990-12-30
AU645260B2 (en) 1994-01-13
WO1991000358A1 (en) 1991-01-10

Similar Documents

Publication Publication Date Title
AU645260B2 (en) A method for introducing molecules, particularly genetic material, into plant cells
JP7046139B2 (ja) 高効率なインビボゲノム編集のための組成物及び方法
Okada et al. Introduction of functional RNA into plant protoplasts by electroporation
CN107488649A (zh) 一种Cpf1和p300核心结构域的融合蛋白、相应的DNA靶向激活系统和应用
Potter [34] Application of electroporation in recombinant DNA technology
Kilby et al. Repeated harvest of vacuole-located secondary product from in vitro grown plant cells using 1.02 MHz ultrasound
JP2574051B2 (ja) インドール酢酸生合成酵素をコードする遺伝子
CN106086031B (zh) 猪肌抑素基因编辑位点及其应用
Nishiguchi et al. Electroporation-mediated infection of tobacco leaf protoplasts with tobacco mosaic virus RNA and cucumber mosaic virus RNA
CN110484538A (zh) 识别猪ROSA26基因的sgRNA及其编码DNA、基因编辑方法、试剂盒和应用
KR19990022728A (ko) 아비딘의 고농도 발현에 의한 식물에서의 웅성생식불능의 유도
WO2018045855A1 (zh) 利用单链核糖核酸转化尼琦青霉孢子并制造蛋白质的方法
CN116024321B (zh) 一种鉴定植物体内转录因子结合位点的方法及应用
CN106754949B (zh) 猪肌抑素基因编辑位点864-883及其应用
EP0333799A1 (en) Modifying living cells
US20190271007A1 (en) Method for direct transformation of exogenous dna into resting spores of penicillium amagasakiense
Van Zeeland et al. Photoreactivation of UV induced cell killing, chromosome aberrations, sister chromatid exchanges, mutations and pyrimidine dimers in Xenopus laevis fibroblasts
RU2663347C1 (ru) Способ доставки биологически активных макромолекул в клетки растений
Langridge et al. [20] Uptake of DNA and RNA into cells mediated by electroporation
JPWO2019244895A1 (ja) 形質転換細胞の製造方法
CN109797170A (zh) 一种检测靶向基因敲除效果的方法
US6596540B2 (en) Method for introduction of an exogenous genetic substance or a physiologically active compound
Potter Protocols for using electroporation to stably or transiently transfect mammalian cells
Hibi Electrotransfection of plant protoplasts with viral nucleic acids
Kościańska et al. Electroporated intact BY-2 tobacco culture cells as a model of transient expression study.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19911231

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANDOZ LTD.

Owner name: SANDOZ-ERFINDUNGEN VERWALTUNGSGESELLSCHAFT M.B.H.

Owner name: SANDOZ-PATENT-GMBH

17Q First examination report despatched

Effective date: 19931213

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19940426